134 related articles for article (PubMed ID: 37914060)
1. Decrease in peripheral natural killer cell level during early pregnancy predicts live birth among women with unexplained recurrent pregnancy loss: a prospective cohort study.
Ou M; Luo L; Yang Y; Yan N; Yan X; Zhong X; Cheong Y; Li T; Ouyang J; Wang Q
Am J Obstet Gynecol; 2024 Jun; 230(6):675.e1-675.e13. PubMed ID: 37914060
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Peroxidase Antibodies and Prospective Live Birth Rate: A Cohort Study of Women with Recurrent Pregnancy Loss.
Bliddal S; Feldt-Rasmussen U; Rasmussen ÅK; Kolte AM; Hilsted LM; Christiansen OB; Nielsen CH; Nielsen HS
Thyroid; 2019 Oct; 29(10):1465-1474. PubMed ID: 31407629
[No Abstract] [Full Text] [Related]
3. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
4. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
5. Chinese herbal medicines for unexplained recurrent miscarriage.
Li L; Dou L; Leung PC; Chung TK; Wang CC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
[TBL] [Abstract][Full Text] [Related]
6. Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: a large cohort study.
Katano K; Suzuki S; Ozaki Y; Suzumori N; Kitaori T; Sugiura-Ogasawara M
Fertil Steril; 2013 Dec; 100(6):1629-34. PubMed ID: 24012195
[TBL] [Abstract][Full Text] [Related]
7. The impact of previous live births on peripheral and uterine natural killer cells in patients with recurrent miscarriage.
Toth B; Vomstein K; Togawa R; Böttcher B; Hudalla H; Strowitzki T; Daniel V; Kuon RJ
Reprod Biol Endocrinol; 2019 Aug; 17(1):72. PubMed ID: 31472670
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
[TBL] [Abstract][Full Text] [Related]
9. Blood CD4
Liao J; Li Y; Li X; Su X; Peng J; Xiao N; Fan X; Chen H; Lu G; Lin G; Cheng L; Gong F
Int Immunopharmacol; 2022 Sep; 110():108960. PubMed ID: 35759810
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss.
Bliddal S; Feldt-Rasmussen U; Forman JL; Hilsted LM; Larsen EC; Christiansen OB; Nielsen CH; Kolte AM; Nielsen HS
Reprod Biomed Online; 2023 Jun; 46(6):995-1003. PubMed ID: 37055255
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss.
Ibrahim MI; Ramy AR; Abdelhamid AS; Ellaithy MI; Omar A; Harara RM; Fathy H; Abolouz AS
Int J Gynaecol Obstet; 2017 Mar; 136(3):298-303. PubMed ID: 28099717
[TBL] [Abstract][Full Text] [Related]
12. Impact of recurrent pregnancy loss history on reproductive outcomes in women undergoing fertility treatment.
Qiu J; Du T; Li W; Zhao M; Zhao D; Wang Y; Kuang Y; Mol BW
Am J Obstet Gynecol; 2023 Jan; 228(1):66.e1-66.e9. PubMed ID: 35970200
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity in women with recurrent miscarriage: Etiology and pregnancy outcome.
Ebina Y; Nishino Y; Deguchi M; Maesawa Y; Nakashima Y; Yamada H
J Reprod Immunol; 2017 Apr; 120():42-47. PubMed ID: 28441552
[TBL] [Abstract][Full Text] [Related]
14. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
[TBL] [Abstract][Full Text] [Related]
15. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
[TBL] [Abstract][Full Text] [Related]
16. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
[TBL] [Abstract][Full Text] [Related]
17. Progestogens for preventing miscarriage: a network meta-analysis.
Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
[TBL] [Abstract][Full Text] [Related]
18. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
[TBL] [Abstract][Full Text] [Related]
19. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
[TBL] [Abstract][Full Text] [Related]
20. Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case-Control Study and Meta-analysis.
Kolanska K; Suner L; Cohen J; Ben Kraiem Y; Placais L; Fain O; Bornes M; Selleret L; Delhommeau F; Feger F; Mathieu d'Argent E; Darai E; Chabbert-Buffet N; Antoine JM; Kayem G; Mekinian A
Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):225-236. PubMed ID: 31147723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
